Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001746 · ClinicalTrials.gov registry record

Screening for Inherited Heart Disease

A clinical trial of Heart Disease and Hypertrophic Cardiomyopathy, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

Completed
Registry status
1
Study location

NCT00001746 is a study of Heart Disease and Hypertrophic Cardiomyopathy that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00001746, a study of Heart Disease and Hypertrophic Cardiomyopathy, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

COMPLETED
Registry status
1
Study location

Study Summary

Genetically inherited heart diseases like hypertrophic cardiomyopathy (HCM) are conditions affecting the heart passed on to family members by abnormalities in genetic information. These conditions are responsible for many heart related deaths and illnesses. Presently, there are several research studies being conducted in order to improve the understanding of disease processes and symptoms associated with genetically inherited heart diseases. This study is designed to determine the eligibility of patients diagnosed with or suspected to have inherited heart disease to participate in these research studies.

Study Locations (1)

Maryland

  • National Heart, Lung and Blood Institute (NHLBI) - Bethesda

Trial Details

FieldValue
Start Date 1998-04
Est. Completion 2003-04

What the Registry Record Tells You About NCT00001746

The ClinicalTrials.gov registry entry for NCT00001746 describes a study currently listed as completed, categorized as an unspecified phase. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Heart Disease appearing as the primary indexed condition, and to 0 interventions.

NCT00001746 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00001746 about?

NCT00001746 is a clinical study titled "Screening for Inherited Heart Disease". Genetically inherited heart diseases like hypertrophic cardiomyopathy (HCM) are conditions affecting the heart passed on to family members by abnormalities in genetic information. These conditions are responsible for many heart related deaths and illnesses. Presently, there are several research stu...

What is the current status of trial NCT00001746?

This trial is currently completed. The study started on 1998-04. Estimated completion is 2003-04.

What conditions does trial NCT00001746 study?

This clinical trial studies the following conditions: Heart Disease, Hypertrophic Cardiomyopathy.

Who is sponsoring clinical trial NCT00001746?

This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00001746 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.